Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME)

Roderick Emile De Bruijn, Peter Mulders, Michael A. Jewett, John Wagstaff, Johan V. Van Thienen, Christian U. Blank, Roland Van Velthoven, Lori Wood, Harm E. van Melick, Maureen J. Aarts, Jean B. Lattouf, Thomas Powles, Igle J. De Jong, Sylvie Rottey, Betrand Tombal, Sandrine Marreaud, Sandra Collette, Laurence Collette, John B. Haanen, Axel Bex*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)437-440
Number of pages4
JournalEuropean Urology
Volume76
Issue number4
DOIs
Publication statusPublished - Oct 2019

Keywords

  • Renal cell carcinoma
  • Cytoreductive nephrectomy
  • Surgical safety
  • RENAL-CELL CARCINOMA
  • PLANNED NEPHRECTOMY
  • EFFICACY
  • THERAPY

Cite this

De Bruijn, R. E., Mulders, P., Jewett, M. A., Wagstaff, J., Van Thienen, J. V., Blank, C. U., Van Velthoven, R., Wood, L., van Melick, H. E., Aarts, M. J., Lattouf, J. B., Powles, T., De Jong, I. J., Rottey, S., Tombal, B., Marreaud, S., Collette, S., Collette, L., Haanen, J. B., & Bex, A. (2019). Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME). European Urology, 76(4), 437-440. https://doi.org/10.1016/j.eururo.2019.06.006